Cliff Asness's CVS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 2.61 M shares of CVS Health Corporation (CVS) worth $207.52 M, representing 0.11% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 53 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 2.55 M shares. Largest reduction occurred in Q1 2018, reducing 3.12 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -437,881 | Reduce 14.34% | 2.61 M | $79.36 |
| Q3 2025 | +774,032 | Add 33.97% | 3.05 M | $75.39 |
| Q2 2025 | -1.41 M | Reduce 38.20% | 2.28 M | $68.57 |
| Q1 2025 | +1.02 M | Add 38.25% | 3.69 M | $67.57 |
| Q4 2024 | -1.39 M | Reduce 34.20% | 2.67 M | $44.45 |
| Q3 2024 | -1.24 M | Reduce 23.37% | 4.05 M | $62.88 |
| Q2 2024 | +1.33 M | Add 33.52% | 5.29 M | $58.74 |
| Q1 2024 | -448,718 | Reduce 10.17% | 3.96 M | $79.48 |
| Q4 2023 | +10,521 | Add 0.24% | 4.41 M | $78.96 |
| Q3 2023 | -554,870 | Reduce 11.20% | 4.4 M | $69.81 |
| Q2 2023 | +247,852 | Add 5.27% | 4.96 M | $68.91 |
| Q1 2023 | +456,802 | Add 10.75% | 4.71 M | $74.31 |
| Q4 2022 | +415,961 | Add 10.85% | 4.25 M | $93.17 |
| Q3 2022 | +460,004 | Add 13.63% | 3.83 M | $95.37 |
| Q2 2022 | +2 M | Add 145.58% | 3.37 M | $92.66 |
| Q1 2022 | +105,598 | Add 8.32% | 1.37 M | $101.21 |
| Q4 2021 | +387,664 | Add 44.01% | 1.27 M | $103.16 |
| Q3 2021 | -88,117 | Reduce 9.09% | 880,808 | $84.86 |
| Q2 2021 | -63,526 | Reduce 6.15% | 968,925 | $83.17 |
| Q1 2021 | -863,630 | Reduce 45.55% | 1.03 M | $75.23 |
| Q4 2020 | -1.06 M | Reduce 35.96% | 1.9 M | $67.30 |
| Q3 2020 | -449,204 | Reduce 13.17% | 2.96 M | $58.23 |
| Q2 2020 | +2.55 M | Add 296.49% | 3.41 M | $64.11 |
| Q1 2020 | +494,266 | Add 135.12% | 860,063 | $59.33 |
| Q4 2019 | +289,344 | Add 378.46% | 365,797 | $73.93 |
| Q3 2019 | -136,377 | Reduce 64.08% | 76,453 | $63.07 |
| Q2 2019 | -276,875 | Reduce 56.54% | 212,830 | $54.49 |
| Q1 2019 | +377,154 | Add 335.10% | 489,705 | $53.50 |
| Q4 2018 | +67,569 | Add 150.21% | 112,551 | $65.52 |
| Q3 2018 | -120,830 | Reduce 72.87% | 44,982 | $78.72 |
| Q2 2018 | -101,489 | Reduce 37.97% | 165,812 | $64.35 |
| Q1 2018 | -3.12 M | Reduce 92.10% | 267,301 | $62.21 |
| Q4 2017 | +1.74 M | Add 105.74% | 3.38 M | $72.50 |
| Q3 2017 | +1.15 M | Add 233.43% | 1.64 M | $81.32 |
| Q2 2017 | +174,060 | Add 54.53% | 493,240 | $80.46 |
| Q1 2017 | -508,905 | Reduce 61.46% | 319,180 | $78.50 |
| Q4 2016 | +229,233 | Add 38.28% | 828,085 | $78.91 |
| Q3 2016 | -205,538 | Reduce 25.55% | 598,852 | $88.99 |
| Q2 2016 | -578,270 | Reduce 41.82% | 804,390 | $95.74 |
| Q1 2016 | -1.23 M | Reduce 47.11% | 1.38 M | $103.73 |
| Q4 2015 | -1.42 M | Reduce 35.15% | 2.61 M | $97.77 |
| Q3 2015 | -771,620 | Reduce 16.07% | 4.03 M | $96.48 |
| Q2 2015 | +942,476 | Add 24.42% | 4.8 M | $104.88 |
| Q1 2015 | +35,316 | Add 0.92% | 3.86 M | $103.21 |
| Q4 2014 | +682,530 | Add 21.72% | 3.82 M | $96.31 |
| Q3 2014 | +97,088 | Add 3.19% | 3.14 M | $79.59 |
| Q2 2014 | -281,200 | Reduce 8.45% | 3.04 M | $75.37 |
| Q1 2014 | +609,149 | Add 22.42% | 3.33 M | $74.86 |
| Q4 2013 | -295,837 | Reduce 9.82% | 2.72 M | $71.57 |
| Q3 2013 | -64,477 | Reduce 2.10% | 3.01 M | $56.75 |
| Q2 2013 | +3.08 M | Add 0.00% | 3.08 M | $57.18 |
| Q4 2012 | +2.27 M | Add 0.00% | 2.27 M | $48.35 |
Cliff Asness's CVS Health Corporation Investment FAQs
Cliff Asness first purchased CVS Health Corporation (CVS) in Q4 2012, acquiring 2,273,415 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held CVS Health Corporation (CVS) for 53 quarters since Q4 2012.
Cliff Asness's largest addition to CVS Health Corporation (CVS) was in Q2 2013, adding 3,077,341 shares worth $175.96 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,614,958 shares of CVS Health Corporation (CVS), valued at approximately $207.52 M.
As of the Q4 2025 filing, CVS Health Corporation (CVS) represents approximately 0.11% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in CVS Health Corporation (CVS) was 5,289,788 shares, as reported at the end of Q2 2024.